BKEMV
Live / Registered — Registered (as of 15 Jul 2025)
What this means for you
Registered since 15 Jul 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Jul 2031: the §8 declaration of use).
Record
- Serial number
- 97240377
- Registration number
- 7868370
- Mark type
- Word mark
- Filed
- 26 Jan 2022
- Published for opposition
- 24 May 2022
- Registered
- 15 Jul 2025
- Next maintenance filing
- §8 declaration of use, due by 15 Jul 2031 (grace period to 15 Jan 2032)
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, blood cell and blood vessel diseases and disorders
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 15 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Apr 2025 — USE AMENDMENT FILED
- 29 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2025 — SOU EXTENSION 5 GRANTED
- 06 Jan 2025 — SOU EXTENSION 5 FILED
- 11 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2024 — SOU EXTENSION 4 GRANTED
- 03 Jun 2024 — SOU EXTENSION 4 FILED